← Leaderboards
Betty B Wu
Talis Biomedical Corporation
$2,219,076
Attributed
$2,219,076
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$2,219,076 · 1
By mechanism
R01$2,219,076 · 1
Top collaborators
No co-investigators on record.
Most similar at Talis Biomedical Corporation
Same institution · by research overlap
- Martin Goldberg$1,178,848
- Hedia Maamar$1,178,848
- Kyle Andrew Tipton$1,109,538
Others in their field
Other Emerging Leaders on “American”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Mark Marino · Venturewell$48,913,644
- Leonard Freedman · Leidos Biomedical Research, Inc.$42,791,770
- Scott Dahm · Association Of Universities For Research In Astronomy, Inc.$39,961,632
- Robert D Blum · Association Of Universities For Research In Astronomy, Inc.$30,497,056
Research focus
AmericanAntibiotic-Resistant OrganismAntibioticsAntibiotic ResistanceAntibiotic TherapyAntimicrobialAntimicrobial ResistanceAntimicrobial SusceptibilityAreaAntibiotic SusceptibilityBacterial ResistanceBaseBioinformatics PipelineBloodBlood SpecimenCaliforniaCandida AlbicansCenters For Disease Control And Prevention (U.S.)ChemistryChicagoClinical DevelopmentBacterial Antibiotic ResistanceCommunicable DiseasesConsumption
Grant awards (2)
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,109,538
R01 · FY2022 · AI · contact PI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,109,538
R01 · FY2021 · AI · contact PI